Health:Further 138 - The Future of Neuropathy Treatment | Stem Cells, Biologics, and Real Recovery Stories
In this episode, Vic speaks with Mark Durante, founder of RiseUP Medical, about the cutting-edge world of biologics and regenerative medicine. They explore how biologics like PRP, PRF, stem cells, and exosomes are being applied in areas such as neuropathy, orthopedic injuries, aesthetics, and sexual health. Mark explains the science behind cell therapies, including mesenchymal stem cells and Wharton's Jelly, and discusses RiseUP’s role in bridging labs and physicians to expand treatment options. They also review recent peer-reviewed studies focused on diabetic and chemo-induced neuropathy and discuss how regenerative treatments may complement or reduce the need for pharmaceuticals and surgery. Mark shares his personal journey from heart failure and near-disability to recovery through biologics, turning his experience into a mission to advance access and innovation in this space.
Rize UpMedical: website
Mark Durante: LinkedIn
Published Research discussed in the show:
- Exploring the Role of Mesenchymal Stem Cell–Derived Exosomes in Diabetic and Chemotherapy‐Induced Peripheral Neuropathy, Molecular Neurobiology (2024).
- Improvements in Diabetic Neuropathy with Topical Human Mesenchymal Stem Cell Conditioned Media, American Journal of Biomedical Science & Research (2024).
- Wharton’s Jelly Tissue Allograft for Connective Tissue Defects Surrounding Nerves in the Tarsal Tunnel: A Retrospective Case Series, Reports by MDPI (2024).